LYST and acute myeloid leukemia: The remaining 8 (29.6%) patients, including 6 from the same family with NHEJ1 mutations and 2 with LYST mutations, developed secondary MDS (sMDS)/AML or lymphoma, with a family history suggestive of FHM.